These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37131085)
1. ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification. Ye W; Wang J; Huang J; He X; Ma Z; Li X; Huang X; Li F; Huang S; Pan J; Jin J; Ling Q; Wang Y; Yu Y; Sun J; Jin J Front Med; 2023 Aug; 17(4):685-698. PubMed ID: 37131085 [TBL] [Abstract][Full Text] [Related]
2. Modulating effects of acyl-CoA synthetase 5-derived mitochondrial Wnt2B palmitoylation on intestinal Wnt activity. Klaus C; Schneider U; Hedberg C; Schütz AK; Bernhagen J; Waldmann H; Gassler N; Kaemmerer E World J Gastroenterol; 2014 Oct; 20(40):14855-64. PubMed ID: 25356045 [TBL] [Abstract][Full Text] [Related]
3. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558 [No Abstract] [Full Text] [Related]
4. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling. Xiao Y; Deng T; Ming X; Xu J Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394 [TBL] [Abstract][Full Text] [Related]
5. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia. Zhai H; Zhao J; Pu J; Zhao P; Wei J Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643 [TBL] [Abstract][Full Text] [Related]
6. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions. Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831 [TBL] [Abstract][Full Text] [Related]
7. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C. Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling. Li C; Xin H; Shi Y; Mu J Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070 [TBL] [Abstract][Full Text] [Related]
9. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Chen L; Hu N; Wang C; Zhao H Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363 [TBL] [Abstract][Full Text] [Related]
10. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway. Xin H; Li C; Wang M Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373 [TBL] [Abstract][Full Text] [Related]
11. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway. Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962 [TBL] [Abstract][Full Text] [Related]
13. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway. Li C; Wang M; Shi Y; Xin H Environ Toxicol; 2022 Aug; 37(8):1934-1943. PubMed ID: 35442555 [TBL] [Abstract][Full Text] [Related]
15. MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia. Liu B; Ma H; Liu Q; Xiao Y; Pan S; Zhou H; Jia L J Exp Clin Cancer Res; 2019 May; 38(1):200. PubMed ID: 31097000 [TBL] [Abstract][Full Text] [Related]
16. A novel dipeptide type inhibitor of the Wnt/β-catenin pathway suppresses proliferation of acute myelogenous leukemia cells. Wakabayashi R; Hattori Y; Hosogi S; Toda Y; Takata K; Ashihara E Biochem Biophys Res Commun; 2021 Jan; 535():73-79. PubMed ID: 33341676 [TBL] [Abstract][Full Text] [Related]
17. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation. Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389 [TBL] [Abstract][Full Text] [Related]
18. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Mashima T; Sato S; Okabe S; Miyata S; Matsuura M; Sugimoto Y; Tsuruo T; Seimiya H Cancer Sci; 2009 Aug; 100(8):1556-62. PubMed ID: 19459852 [TBL] [Abstract][Full Text] [Related]
19. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046 [TBL] [Abstract][Full Text] [Related]
20. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance. Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]